Compassionate Use of Domperidone for Refractory Gastroparesis

Summary

The purpose of this program is to allow the use of domperidone in children from 12 to 21 years of age with symptoms related to motility disorders and Gastroesophageal reflux disease (GERD) who have failed all the standard treatments for their condition.

Timeline

Start

2013-04

Primary completion

2035-12

Completion

2035-12

Drugs

Indications